Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

Roche Basel Switzerland

Roche digs out soil drug discovery deal with Lodo

Lodo is raiding the rich microbial world of soil for potential new drugs

AstraZeneca AZ

Maintenance OK boosts AstraZeneca’s Lynparza in Europe

New pill formulation also helps AZ and MSD against competitors in PARP class

- PMLiVE

NHS England pledges to streamline clinical trial setup

The process will also target the procedure for reimbursements in additional treatment costs

- PMLiVE

Daily Brief: Deal done, Takeda to cut $1.4bn, Brexit latest, Valeant rebrands

A rapid round-up of the top pharma, biotech and healthcare news

Joanne – Celebrating 10 magical #LucidLife years

Joanne reflects on her ten years at Lucid Group and how it's transitioned from a small start-up to a global family of healthcare communication companies who bring magic to their...

Lucid Group Communications Limited

Lucid Culture

Our culture is fundamental to the delivery of transformation. Harnessing the talent and ambitions of those we work with empowers us to deliver our magic.

Lucid Group Communications Limited

Creating a successful global compliance programme

Meeting the challenges and finding solutions as multinationals seek to balance different priorities and needs

- PMLiVE

Passing fad or game changer?

Outcomes-based contracting in the life science sector

- PMLiVE

Daily Brief: Takeda seals $62bn Shire deal, Autolus IPO, Gottlieb warning

A rapid round-up of the top pharma, biotech and healthcare news

- PMLiVE

FDA clears first-line use for J&J’s Darzalex

Front-line approval a milestone for blockbuster-tipped myeloma drug

- PMLiVE

Unlimited Group appoints group managing director

Michael Richards joins the group from VCCP

- PMLiVE

KYNE bolsters digital offering

Medit will take the helm of KYNE’s digital strategy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links